Croda International (LON:CRDA) Stock Price Crosses Below 200 Day Moving Average – Here’s Why

Croda International Plc (LON:CRDA) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,740.97 and traded as low as GBX 2,660. Croda International shares last traded at GBX 2,757, with a volume of 346,342 shares traded.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Berenberg Bank lifted their price objective on Croda International from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a research report on Thursday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price target on Croda International from GBX 3,000 to GBX 3,100 and gave the company a “hold” rating in a report on Thursday, October 16th. Jefferies Financial Group downgraded shares of Croda International to a “hold” rating and reduced their price target for the stock from GBX 3,100 to GBX 3,000 in a research report on Tuesday, November 11th. Finally, Citigroup lowered their price objective on shares of Croda International from GBX 3,300 to GBX 3,050 and set a “neutral” rating for the company in a research report on Friday, October 3rd. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of GBX 3,112.50.

Croda International Trading Up 1.1%

The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The business’s 50-day simple moving average is GBX 2,753.53 and its 200-day simple moving average is GBX 2,740.97. The company has a market capitalization of £3.85 billion, a price-to-earnings ratio of 17.90, a P/E/G ratio of 1.40 and a beta of 0.74.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.